Equity Research, Broker Reports, and media content on Sanofi

  • Access the latest forecasts, broker valuations, multiples, and video content from the city about Sanofi
  • See live updates from analysts, company announcements, and other news in a personalised/single dashboard

Research, Charts & Company Announcements

Research Tree provides access to ongoing research coverage, media content and regulatory news on Sanofi. We currently have 12 research reports from 1 professional analysts.

Open
82.7
Volume
0.1m
Range
82.5/83.3
Market Cap
106,250,732,158m
52 Week
67.2/93.0
Date Source Announcement
09Nov17 11:59 GNW Sanofi, Principia agree to develop multiple sclerosis drug candidate
02Nov17 14:45 GNW Sanofi and Alnylam present positive complete results from APOLLO Phase 3 study of investigational patisiran in hereditary ATTR (hATTR) amyloidosis patients with polyneuropathy
02Nov17 06:29 GNW Sanofi : Q3 2017 Business EPS up 1.1% at CER FY 2017 Guidance Confirmed
31Oct17 10:58 GNW Sanofi : Dupilumab Significantly Reduced Steroid Use, Asthma Attacks, and Improved Lung Function in a Phase 3 Study of People with Severe Steroid-Dependent Asthma
24Oct17 21:05 GNW Sanofi Files Suit in the U.S. to Defend Its Patent Rights on Lantus® and Lantus® SoloStar®
16Oct17 13:01 GNW Sanofi and Regeneron Announce Positive Phase 2 Study Results for Dupilumab in Patients With Active Moderate-to-Severe Eosinophilic Esophagitis
12Oct17 06:01 GNW Sanofi invests €170 million in new vaccine production facility in France
  • Frequency of research reports

     

  • Research reports on

    Sanofi

  • Providers covering

    Sanofi